Caprock Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-901
| Closed | -$270K | – | 1055 |
|
|
2024
Q3 | $270K | Sell |
901
-204
| -18% | -$61.2K | 0.01% | 756 |
|
|
2024
Q2 | $364K | Buy |
1,105
+68
| +7% | +$22.4K | 0.01% | 627 |
|
|
2024
Q1 | $410K | Sell |
1,037
-10
| -1% | -$3.96K | 0.02% | 469 |
|
|
2023
Q4 | $369K | Sell |
1,047
-79
| -7% | -$27.8K | 0.02% | 478 |
|
|
2023
Q3 | $422K | Sell |
1,126
-61
| -5% | -$22.9K | 0.03% | 400 |
|
|
2023
Q2 | $454K | Buy |
1,187
+147
| +14% | +$56.2K | 0.03% | 397 |
|
|
2023
Q1 | $360K | Buy |
+1,040
| New | +$360K | 0.03% | 442 |
|
|
2022
Q3 | – | Sell |
-773
| Closed | -$234K | – | 609 |
|
|
2022
Q2 | $234K | Buy |
773
+78
| +11% | +$23.6K | 0.02% | 457 |
|
|
2022
Q1 | $285K | Buy |
695
+113
| +19% | +$46.3K | 0.03% | 443 |
|
|
2021
Q4 | $273K | Buy |
+582
| New | +$273K | 0.02% | 462 |
|